These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
226 related items for PubMed ID: 8474005
1. Effects of quinapril, a new angiotensin-converting enzyme inhibitor, on vasoconstrictor activity in the isolated, perfused mesenteric vasculature of hypertensive rats. Major TC, Overhiser RW, Taylor DG, Panek RL. J Pharmacol Exp Ther; 1993 Apr; 265(1):187-93. PubMed ID: 8474005 [Abstract] [Full Text] [Related]
2. Angiotensin-converting enzyme inhibition attenuates arterial constrictor responses in experimental hypertension. Kähönen M, Mäkynen H, Wu X, Arvola P, Pekki A, Pörsti I. J Pharmacol Exp Ther; 1996 Jun; 277(3):1701-9. PubMed ID: 8667241 [Abstract] [Full Text] [Related]
3. Secretory dysfunction of vascular endothelium limits the effect of angiotensin converting enzyme inhibitor quinapril on aggregation of erythrocytes in experimental hypertension. Korbut RA, Madej J, Adamek-Guzik T, Korbut R. J Physiol Pharmacol; 2003 Sep; 54(3):397-408. PubMed ID: 14566078 [Abstract] [Full Text] [Related]
4. Effects of the antihypertensive agent, cicletanine, on noradrenaline release and vasoconstriction in perfused mesenteric artery of SHR. Nasa Y, Yoshida H, Urata M, Uchibayashi K, Tsunoda Y, Kamigata K, Takeo S. Br J Pharmacol; 1998 Feb; 123(3):427-34. PubMed ID: 9504383 [Abstract] [Full Text] [Related]
5. Evidence for a functional tissue renin-angiotensin system in the rat mesenteric vasculature and its involvement in regulating blood pressure. Weishaar RE, Panek RL, Major TC, Simmerman J, Rapundalo ST, Taylor DG. J Pharmacol Exp Ther; 1991 Feb; 256(2):568-74. PubMed ID: 1847201 [Abstract] [Full Text] [Related]
6. Angiotensin-converting enzyme inhibition with quinapril (CI-906) and captopril in spontaneously hypertensive rats with suppressed renin-angiotensin system. Säynävälammi P, Pörsti I. Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):325-31. PubMed ID: 3309510 [Abstract] [Full Text] [Related]
7. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats. Ishimitsu T, Honda T, Ohta S, Akashiba A, Takahashi T, Kameda T, Yoshii M, Minami J, Takahashi M, Ono H, Matsuoka H. Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768 [Abstract] [Full Text] [Related]
8. Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2. Henrion D, Dechaux E, Dowell FJ, Maclour J, Samuel JL, Lévy BI, Michel JB. Br J Pharmacol; 1997 May; 121(1):83-90. PubMed ID: 9146891 [Abstract] [Full Text] [Related]
9. The effects of quinapril and atorvastatin on artery structure and function in adult spontaneously hypertensive rats. Yang L, Gao YJ, Lee RM. Eur J Pharmacol; 2005 Aug 22; 518(2-3):145-51. PubMed ID: 16024013 [Abstract] [Full Text] [Related]
10. Endothelial function in spontaneously hypertensive rats: influence of quinapril treatment. Kähönen M, Mäkynen H, Wu X, Arvola P, Pörsti I. Br J Pharmacol; 1995 Jul 22; 115(5):859-67. PubMed ID: 8548188 [Abstract] [Full Text] [Related]
11. Influence of dietary salts on the cardiovascular effects of low-dose combination of ramipril and felodipine in spontaneously hypertensive rats. Mervaala EM, Malmberg L, Teräväinen TL, Laakso J, Vapaatalo H, Karppanen H. Br J Pharmacol; 1998 Jan 22; 123(2):195-204. PubMed ID: 9489606 [Abstract] [Full Text] [Related]
12. Effects of the angiotensin-converting enzyme inhibitor quinapril on renal function in rats. Graziano MJ, Dethloff LA, Griffin HE, Pegg DG. Arch Int Pharmacodyn Ther; 1993 Jan 22; 324():87-104. PubMed ID: 8297189 [Abstract] [Full Text] [Related]
13. Inhibition of angiotensin-converting enzyme with quinapril (CI-906): investigation of antihypertensive mechanisms in spontaneously hypertensive rats. Säynävälammi P, Pörsti I, Nurmi AK, Seppälä E, Metsä-Ketelä T, Tuomisto L, Manninen V, Vapaatalo H. J Pharmacol Exp Ther; 1986 Apr 22; 237(1):246-51. PubMed ID: 3007740 [Abstract] [Full Text] [Related]
14. Quinapril treatment and arterial smooth muscle responses in spontaneously hypertensive rats. Arvola P, Ruskoaho H, Wuorela H, Pekki A, Vapaatalo H, Pörsti I. Br J Pharmacol; 1993 Apr 22; 108(4):980-90. PubMed ID: 8485636 [Abstract] [Full Text] [Related]
15. Inhibitory effect of melatonin on alpha1-adrenergic-induced vasoconstriction in mesenteric beds of spontaneously hypertensive rats. Girouard H, de Champlain J. Am J Hypertens; 2004 Apr 22; 17(4):339-46. PubMed ID: 15062888 [Abstract] [Full Text] [Related]
16. Improvement of endothelial dysfunction by angiotensin II blockade accompanied by induction of vascular hepatocyte growth factor system in diabetic spontaneously hypertensive rats. Matsumoto K, Morishita R, Tomita N, Moriguchi A, Komai N, Aoki M, Matsumoto K, Nakamura T, Higaki J, Ogihara T. Heart Vessels; 2003 Mar 22; 18(1):18-25. PubMed ID: 12644877 [Abstract] [Full Text] [Related]
17. The effects of perfusion rate and NG-nitro-L-arginine methyl ester on cirazoline- and KCl-induced responses in the perfused mesenteric arterial bed of rats. Adeagbo AS, Tabrizchi R, Triggle CR. Br J Pharmacol; 1994 Jan 22; 111(1):13-20. PubMed ID: 7912152 [Abstract] [Full Text] [Related]
18. Plasma digoxin immunoreactivity and arterial potassium relaxation after quinapril therapy in hypertensive rats. Kähönen M, Doris PA, Mäkynen H, Pörsti I. J Pharmacol Exp Ther; 1995 Nov 22; 275(2):832-7. PubMed ID: 7473173 [Abstract] [Full Text] [Related]
19. Characterization of the alpha-1 adrenoceptors in the mesenteric vasculature from deoxycorticosterone-salt hypertensive rats: studies on vasoconstriction, radioligand binding and postreceptor events. Suzuki S, Takata Y, Kubota S, Ozaki S, Kato H. J Pharmacol Exp Ther; 1994 Feb 22; 268(2):576-83. PubMed ID: 8113968 [Abstract] [Full Text] [Related]
20. Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats. Zolk O, Flesch M, Schnabel P, Teisman AC, Pinto YM, van Gilst WH, Paul M, Böhm M. Br J Pharmacol; 1998 Feb 22; 123(3):405-12. PubMed ID: 9504380 [Abstract] [Full Text] [Related] Page: [Next] [New Search]